Tripterygium glycosides ameliorates ulcerative colitis through the NLRP3/Caspase-1 signaling pathway

Tripterygium glycosides ameliorates ulcerative colitis through the NLRP3/Caspase-1 signaling pathway

JIANG Xintong, XU Jiaqi, YUE Jianru

PDF(5303 KB)

Welcome to Current Immunology, Today is

PDF(5303 KB)

Current Immunology ›› 2026, Vol. 46 ›› Issue (1) : 78-84.

Tripterygium glycosides ameliorates ulcerative colitis through the NLRP3/Caspase-1 signaling pathway

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 46(1): 78-84

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(5303 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉